en

PRODUCT DETAIL

Naloxone Polpharma

Code 94763
MA number 19/0228/90-CS
Product Form: sol inj 10x0,4 mg/1 ml (amp.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
MAH, country: Zakłady Farmaceutyczne Polpharma S.A., Poland
Therapeutic Class: 19 - ANTIDOTA, DETOXICANTIA
ATC:
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB15 Naloxone
Shelf life: 36
Container: glass ampoule
Route of admin.: Subcutaneous, intramuscular and intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 01.10.1990
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Naloxone Polpharma_sol inj_03_2024.pdf  
SPC: SPC_Naloxone Polpharma_sol inj_03_2024.pdf  
Safety feature Yes
Data update: 27.02.2024
eu-flag.png sk-flag.png